Masako Toyosaki and Shinichiro Machida have received honoraria for lectures from Janssen Pharmaceutical K.K. Daisuke Tomizawa has received honoraria for lectures from AbbVie Inc., Amgen Inc., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Meiji Seika Pharmatech Co., Ltd., Miyarisan Pharmaceutical Co., Ltd., Nihon Servier Co., Ltd., Nippon Shinyaku Co., Ltd., Novartis Pharma K.K., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd. and Taiho Pharmaceutical Co., Ltd.; has received consulting fees from Amgen Inc.; and has served on advisory boards for Meiji Seika Pharmatech Co., Ltd. and Novartis Pharma K.K. Masaya Okada has no conflicts of interest to declare. Masashi Sawa has received honoraria for lectures from AbbVie, Amgen, Asahi Kasei Corporation, Astellas Pharma Inc., AstraZeneca K.K., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., CSL Behring K.K., Daiichi Sankyo Co., Ltd., Eisai Co. Ltd., Janssen Pharmaceutical K.K., Kyowa Kirin Co., Ltd., MSD, Mundipharma K.K., Nippon Kayaku Co., Ltd., Nippon Shinyaku Co., Ltd., Novartis Pharma K.K., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd, Pfizer, Sanofi K.K., Sumitomo Pharma Co., Ltd., SymBio Pharmaceuticals Ltd. and Takeda Pharmaceutical Co., Ltd. Yasunori Ueda has received honoraria for lectures and has served on advisory boards for Sanofi K.K. Ai Omi and Yosuke Koroki are employees of Janssen Pharmaceutical K.K. Yosuke Koroki owns employee stocks at Johnson & Johnson. Takanori Teshima is the President of the Japanese Society for Transplantation and Cellular Therapy, and the Director of the Japanese Society of Hematology and the Japan Society of Transfusion Medicine and Cell Therapy; has received grants for research from Asahi Kasei Pharma Corporation, Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Fuji Pharma Co., Ltd., Kyowa Kirin Co., Ltd., Nippon Shinyaku Co., Ltd., Ono Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., and Sumitomo Pharma Co., Ltd.; has received contracts for clinical trials from Astellas Pharma Inc. and Otsuka Pharmaceutical Co., Ltd.; has received honoraria for lectures from Astellas Pharma Inc., AbbVie GK, Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., Kyowa Kirin Co., Ltd., Merck & Co., Inc., Nippon Shinyaku Co., Ltd., Novartis Pharma K.K. and Sumitomo Pharma Co., Ltd.; and has received consulting fees from Kyowa Kirin Co., Ltd., Meiji Seika Pharma Co., Ltd., Nippon Shinyaku Co., Ltd. and Otsuka Pharmaceutical Co., Ltd.